Merck 2014 Annual Report Download - page 173

Download and view the complete annual report

Please find page 173 of the 2014 Merck annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 271

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200
  • 201
  • 202
  • 203
  • 204
  • 205
  • 206
  • 207
  • 208
  • 209
  • 210
  • 211
  • 212
  • 213
  • 214
  • 215
  • 216
  • 217
  • 218
  • 219
  • 220
  • 221
  • 222
  • 223
  • 224
  • 225
  • 226
  • 227
  • 228
  • 229
  • 230
  • 231
  • 232
  • 233
  • 234
  • 235
  • 236
  • 237
  • 238
  • 239
  • 240
  • 241
  • 242
  • 243
  • 244
  • 245
  • 246
  • 247
  • 248
  • 249
  • 250
  • 251
  • 252
  • 253
  • 254
  • 255
  • 256
  • 257
  • 258
  • 259
  • 260
  • 261
  • 262
  • 263
  • 264
  • 265
  • 266
  • 267
  • 268
  • 269
  • 270
  • 271

168 CONSOLIDATED FINANCIAL STATEMENTS → Consolidated Income Statement
CONSOLIDATED INCOME STATEMENT
€million Note 2014 2013
Sales → 23 11,291.5 10,700.1
Royalty, license and commission income → 24 209.3 395.0
Total revenues 11,500.8 11,095.1
Cost of sales1→ 25 – 3,526.4 – 3,041.7
(of which: amortization of intangible assets)1 (– 94.0) (– 49.2)
Gross profit1 7,974.4 8,053.4
Marketing and selling expenses1→ 26 – 3,104.9 – 3,088.5
(of which: amortization of intangible assets)1 (– 719.0) (– 762.0)
Royalty, license and commission expenses → 27 – 537.5 – 567.0
Administration expenses → 28 – 608.6 – 562.4
Research and development costs1→ 29 –1,703.7 –1,506.6
(of which: amortization of intangible assets)1 (– 3.8) (– 2.3)
Other operating expenses and income → 30 – 257.7 – 718.1
Operating result (EBIT) 1,762.0 1,610.8
Financial result → 31 – 205.0 – 222.2
Profit before income tax 1,557.0 1,388.6
Income tax → 32 – 392.2 –179.5
Profit after tax 1,164.8 1,209.1
of which attributable to MerckKGaA, Darmstadt, Germany, shareholders (net income) 1,157.3 1,202.2
of which attributable to non-controlling interests → 33 7.5 6.9
Earnings per share (in €) → 34
basic2 2.66 2.77
diluted2 2.66 2.77
1 The disclosure of amortization of intangible assets (excluding software) has been changed. See Note “Accounting and measurement principles”.
2 Taking into account the share split; previous year’s figures have been adjusted accordingly. See Note “Earnings per share”.